|
Volumn 50, Issue 5, 2005, Pages 839-841
|
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication
|
Author keywords
Eradication; Helicobacter pylori; Lansoprazole; Omeprazole; PPI
|
Indexed keywords
LANSOPRAZOLE;
OMEPRADEX;
OMEPRAZOLE;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CONTROLLED STUDY;
DATA BASE;
DRUG CHOICE;
DRUG EFFICACY;
DRUG INDICATION;
ERADICATION THERAPY;
FEMALE;
HEALTH INSURANCE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
ISRAEL;
LOGISTIC REGRESSION ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SEX DIFFERENCE;
STATISTICAL SIGNIFICANCE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UREA BREATH TEST;
VALIDATION PROCESS;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGED;
AGED, 80 AND OVER;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
FEMALE;
GASTROINTESTINAL DISEASES;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
ISRAEL;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PROTON PUMPS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 18844391968
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1007/s10620-005-2649-y Document Type: Article |
Times cited : (7)
|
References (9)
|